Abstract
Ewing sarcoma is part of the Ewing sarcoma family of tumors (ESFT) and typically affects adolescents and young adults. Ewing sarcoma usually presents as an osteolytic lesion but can also have an osteosclerotic component and, in most cases, has an associated soft-tissue mass. This variable bone response can result in varying levels of uptake on bone scintigraphy and FDG-PET/CT, and both techniques provide complementary information.
References
Murphey MD, Senchak LT, Mambalam PK, Logie CI, Klassen-Fischer MK, Kransdorf MJ. From the radiologic pathology archives: ewing sarcoma family of tumors: radiologic-pathologic correlation. Radiographics. 2013;33(3):803–31.
National Comprehensive Cancer Network. Bone cancer (Version 1.2023) 2022. Available from https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf
Seth N, Seth I, Bulloch G, Siu AHY, Guo A, Chatterjee R, et al. (18) F-FDG PET and PET/CT as a diagnostic method for Ewing sarcoma: a systematic review and meta-analysis. Pediatr Blood Cancer. 2022;69(3):e29415.
Ulaner GA, Magnan H, Healey JH, Weber WA, Meyers PA. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? AJR Am J Roentgenol. 2014;202(4):859–67.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Van den Wyngaert, T. (2023). Tumors: Ewing Sarcoma. In: Van den Wyngaert, T., Gnanasegaran, G., Strobel, K. (eds) Clinical Atlas of Bone SPECT/CT. Springer, Cham. https://doi.org/10.1007/978-3-031-26449-8_114
Download citation
DOI: https://doi.org/10.1007/978-3-031-26449-8_114
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-26448-1
Online ISBN: 978-3-031-26449-8
eBook Packages: MedicineReference Module Medicine